We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ROOBY Trial Follow-up Extension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01924442
Recruitment Status : Completed
First Posted : August 16, 2013
Results First Posted : June 7, 2019
Last Update Posted : June 7, 2019
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development

Study Type Observational
Study Design Observational Model: Cohort;   Time Perspective: Prospective
Conditions All Cause Mortality
MACE
Enrollment 2203
Recruitment Details  
Pre-assignment Details  
Arm/Group Title On-Pump Off-Pump
Hide Arm/Group Description Cardiac bypass using Heart Lung Machine Cardiac bypass surgery on beating heart
Period Title: Overall Study
Started 1099 1104
Completed 1059 967
Not Completed 40 137
Arm/Group Title On-Pump Off-Pump Total
Hide Arm/Group Description Cardiac bypass using Heart Lung Machine Cardiac bypass surgery on beating heart Total of all reporting groups
Overall Number of Baseline Participants 1099 1104 2203
Hide Baseline Analysis Population Description
[Not Specified]
Age, Categorical  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
<=18 years
0
   0.0%
0
   0.0%
0
   0.0%
Between 18 and 65 years
699
  63.6%
671
  60.8%
1370
  62.2%
>=65 years
400
  36.4%
433
  39.2%
833
  37.8%
Age, Continuous  
Mean (Standard Deviation)
Unit of measure:  Years
Number Analyzed 1099 participants 1104 participants 2203 participants
62.5  (8.5) 63.0  (8.5) 62.74  (8.49)
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
Female
6
   0.5%
7
   0.6%
13
   0.6%
Male
1093
  99.5%
1097
  99.4%
2190
  99.4%
Race/Ethnicity, Customized  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
Black
93
   8.5%
77
   7.0%
170
   7.7%
Hispanic
52
   4.7%
71
   6.4%
123
   5.6%
White
926
  84.3%
931
  84.3%
1857
  84.3%
Other
27
   2.5%
25
   2.3%
52
   2.4%
Unknown
1
   0.1%
0
   0.0%
1
   0.0%
Urgent Status requiring surgery within 12 to 72 hours  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
146
  13.3%
146
  13.2%
292
  13.3%
Chronic obstructive pulmonary disease (COPD)  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
238
  21.7%
220
  19.9%
458
  20.8%
Peripheral vascular disease  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
163
  14.8%
179
  16.2%
342
  15.5%
Diabetes  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
491
  44.7%
470
  42.6%
961
  43.6%
Hypertension  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
952
  86.6%
948
  85.9%
1900
  86.2%
History of Depression  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 1099 participants 1104 participants 2203 participants
120
  10.9%
146
  13.2%
266
  12.1%
1.Primary Outcome
Title Long-term All Cause Mortality Between On-pump and Off-pump Patients.
Hide Description Five-year mortality was initially assessed by matching the participants in the follow-up study to data in the VA Vital Status File and the National Death Index, which provided cause-of-death codes according to the International Classification of Diseases, 10th Revision.
Time Frame 5 Years
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title On-Pump Off-Pump
Hide Arm/Group Description:
Cardiac bypass using Heart Lung Machine
Cardiac bypass surgery on beating heart
Overall Number of Participants Analyzed 1099 1104
Measure Type: Count of Participants
Unit of Measure: Participants
All cause death
131
  11.9%
168
  15.2%
Composite MACE outcome with death
298
  27.1%
342
  31.0%
No MACE outcome
670
  61.0%
594
  53.8%
2.Secondary Outcome
Title Long-term Major Adverse Cardiovascular Event (MACE) Between On-pump and Off-pump Patients
Hide Description Secondary outcomes included the 5-year rates of death from cardiac causes, repeat revascularization and nonfatal myocardial infarction.
Time Frame 5 years
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title On-Pump Off-Pump
Hide Arm/Group Description:
Cardiac bypass using Heart Lung Machine
Cardiac bypass surgery on beating heart
Overall Number of Participants Analyzed 1099 1104
Measure Type: Count of Participants
Unit of Measure: Participants
Death from cardiac causes
58
   5.3%
70
   6.3%
Acute myocardial infarction
105
   9.6%
134
  12.1%
Repeat revascularization procedure
131
  11.9%
145
  13.1%
Percutaneous coronary intrevention
127
  11.6%
131
  11.9%
Repeat Coronary artery bypass grafting (CABG)
5
   0.5%
16
   1.4%
No MACE outcome (non cardiac deaths included)
673
  61.2%
608
  55.1%
Time Frame 5 Years
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title On-Pump Off-Pump
Hide Arm/Group Description Cardiac bypass using Heart Lung Machine Cardiac bypass surgery on beating heart
All-Cause Mortality
On-Pump Off-Pump
Affected / at Risk (%) Affected / at Risk (%)
Total   131/1099 (11.92%)      168/1104 (15.22%)    
Hide Serious Adverse Events
On-Pump Off-Pump
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total   426/1099 (38.76%)      496/1104 (44.93%)    
Cardiac disorders     
Death from cardiac causes   58/1099 (5.28%)  58 70/1104 (6.34%)  70
Acute myocardial infarction   105/1099 (9.55%)  105 134/1104 (12.14%)  134
Repeat revascularization procedure   131/1099 (11.92%)  131 145/1104 (13.13%)  145
Percutaneous coronary intervention   127/1099 (11.56%)  127 131/1104 (11.87%)  131
Repeat Coronary artery bypass grafting (CABG)   5/1099 (0.45%)  5 16/1104 (1.45%)  16
Indicates events were collected by systematic assessment
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
On-Pump Off-Pump
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total   0/1099 (0.00%)      0/1104 (0.00%)    
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Frederick Grover, MD
Organization: VA Medical Center, Denver, Colorado
Phone: 303-724-2798
EMail: Frederic.Grover@ucdenver.edu
Layout table for additonal information
Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT01924442    
Other Study ID Numbers: 517-FS
First Submitted: July 18, 2013
First Posted: August 16, 2013
Results First Submitted: September 1, 2017
Results First Posted: June 7, 2019
Last Update Posted: June 7, 2019